Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
Kiyokazu Atake, Reiji Yoshimura, Hikaru Hori, Asuka Katsuki, Jun Nakamura Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan Purpose: This study investigated the relationships among the plasma levels of catecholamine metabolites, the clinical...
Guardado en:
Autores principales: | Atake K, Yoshimura R, Hori H, Katsuki A, Nakamura J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb00d7a23f6f452086acb0603aabc9da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Affect-modulated startle: interactive influence of catechol-O-methyltransferase Val158Met genotype and childhood trauma.
por: Benedikt Klauke, et al.
Publicado: (2012) -
The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome.
por: Pontus Karling, et al.
Publicado: (2011) -
The catechol-O-methyltransferase (COMT) val158met polymorphism affects brain responses to repeated painful stimuli.
por: Marco L Loggia, et al.
Publicado: (2011) -
Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions
por: Winnie W Leung, et al.
Publicado: (2007) -
COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study
por: Hayashi K, et al.
Publicado: (2014)